Narrative review discusses inflammaging and immunosenescence in older adults with colorectal cancer
This narrative review focuses on the intersection of inflammaging and immunosenescence within the context of colorectal cancer in older adults. The scope of the article is to synthesize current understanding of these biological processes in this specific patient population. No specific sample size or follow-up duration is reported for the evidence discussed within this commentary.
The authors highlight that fundamental immunological mechanisms which underlie this risk remain incompletely understood. This gap in knowledge limits the ability to draw definitive causal conclusions or establish precise risk estimates from the available literature. The review does not report specific adverse events, tolerability data, or primary outcomes associated with interventions.
Despite these limitations, the practice relevance of the review is that it may guide future endeavor in biomarker discovery, prevention, and therapeutic intervention. Clinicians should interpret these findings as a call for further research rather than established clinical guidelines. The certainty of the conclusions is constrained by the incomplete understanding of the underlying immunology.